Liver Failure
Gastroenterology·MeSH: Liver Failure
Prevalence
30.0 / 100K
9 drugs in development·7 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| felbamate | ANI PHARMACEUTICALS INC (ANIP) |
Phase 3(2)
Phase 2(1)
| Drug | Company |
|---|---|
| f573 | GYRE THERAPEUTICS, INC. (GYRE) |
Phase 1(4)
N/A(1)
| Drug | Company |
|---|---|
| Midodrine | Valneva SE (VALN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Liver Failure?
BioSniper tracks 9 drugs in development for Liver Failure across 7 companies.
How many clinical trials target Liver Failure?
There are 1 clinical trial targeting Liver Failure tracked by BioSniper.
What is the prevalence of Liver Failure?
The estimated prevalence of Liver Failure is approximately 30.0 per 100,000 population.
Deep-dive into Liver Failure
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis